MMP12 and chronic obstructive pulmonary disease: Targeting the activity of transient receptor potential mucolipin 3 (TRPML3) affects endolysosomal trafficking and phagocytosis of MMP-12 in pulmonary macrophages 39, ultimately reducing COPD-related emphysema incidence.